Polymorphs of a c-Met/HGFR inhibitor

Details for Australian Patent Application No. 2006323025 (hide)

Owner Pfizer Products Inc.

Inventors Cui, Jingrong Jean; Tran-Dube, Michelle Bich

Agent Shelston IP

Pub. Number AU-B-2006323025

PCT Pub. Number WO2007/066185

Priority 60/742,676 05.12.05 US

Filing date 23 November 2006

Wipo publication date 14 June 2007

Acceptance publication date 5 July 2012

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/4155 - not condensed and containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

Event Publications

12 June 2008 PCT application entered the National Phase

  PCT publication WO2007/066185 Priority application(s): WO2007/066185

5 July 2012 Application Accepted

  Published as AU-B-2006323025

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006323027-Method of treating abnormal cell growth

2006323018-Capsules or microcapsules with stable outer hydrophilic layer for rapid buccal disintegration